medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2010, Number 05

<< Back

Ginecol Obstet Mex 2010; 78 (05)

Clinical practice guidelines. Recurrent infection of the urinary tract in women

Velázquez MP, Romero-Nava LE, López ÁDR, Quiroz-Garza G

Language: Spanish
References: 60
Page: 437-459
PDF size: 600.54 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Barclay L. New Guidelines for Management of Urinary Tract Infection in Nonpregnant Women. Obstet Gynecol 2008;111:785-794.

  2. Schaeffer AJ. Infection of the urinary tract. Walsh PC, editor. Cambell’s Urology, 8th ed. Philadelphia: Saunders, 2002;p:515-602.

  3. Valdevenito SJP. Recurrent urinary tract infection in women. Rev Chil Infect 2008;25(4):268-276.

  4. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990;80:331-333.

  5. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003;301:105-107.

  6. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 2004;12:424-430.

  7. Ochoa SC, Eiros BJM, Pérez MCL, y cols. Etiología de las infecciones del tracto urinario y sensibilidad de los uropatógenos a los antimicrobianos. Rev Esp Quimioterap 2005;18(2):124-135.

  8. Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis 2004;4:631-635.

  9. Svanborg C, Goldaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997;11:513-529.

  10. Romero NLE, Rodríguez CS, Velázquez SMP, Rasch JR. Low urinary tract infection and cystoscopic findings in Urogynecology Service in the Instituto Nacional de Perinatología. Ginecol Obstet Mex 2003;71:508-514.

  11. Guidelines & Protocols. Avisory Committee. Urinary Tract Infections-Macroscopic and Microscopic Urinalysis and Investigation of Urinary Tract Infections. British Columbia Medical Association. Ministry of Health. Website: .

  12. Lawrentschuk N, Ooi J, Pang A, et al. Cystoscopy in women with recurrent urinary tract infection. Int J Urol 2006;13(4):350-353.

  13. Fair WR, Mcclennan BL, Jost RG. Are excretory urograms necessary in evaluating women with urinary tract infection? J Urol 1979;121:313-315.

  14. Curtis N. Management of urinary tract infections: historical perspective and current strategies: part 2. Modern Management. J Urol 2005;173:27-32.

  15. Engel G, Schaeffer AJ, Grayhack JT, Wendel EF. The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol 1980;123:190-191.

  16. Fowler JE, Pulaski ET. Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection. A prospective study. N Engl J Med 1981;304:462-465.

  17. Fairchild TN, Shuman W, Berger RE. Radiographic studies for women with recurrent urinary tract infections. J Urol 1982;128:344-345.

  18. Clinical Knowledge Summaries Chlamydia, uncomplicated, genital (women). Last revised in May 2006.

  19. Burkhard FC, Blick N, Hochreiter WW, Studer UE. Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol 2004;172(1):232-235.

  20. Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother 2000;46(Suppl. 1):1-7; discussion 63-65.

  21. Ena J, Arjona F, Martínez-Peinado C, et al. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 2006;68:1169-1174.

  22. Arredondo GJL, et al. Resistance of uropathogenic bacteria to first-line antibiotics in Mexico City: a multicenter, susceptibility analysis. Curr Ther Res Clin Exp 2007;68.

  23. Milo G, Katchman E, Paul M, et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004682. DOI: 10.1002/14651858.CD004682.pub2.

  24. Warren JW, Abrutyn E, Hebel R, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and pyelonephritis in women. Clin Infect Dis 1999;29:745-748.

  25. Rafalsky VV, Andreeva IV, Rjabkova EL. Quinolones for uncomplicated acute cystitis in women. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD003597. DOI:10.1002/14651858.CD003597.pub2.

  26. Hernández MS, García JA, Muñoz JL. In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin. Rev Esp Quimioter 2009;22(1):25-29.

  27. Bergogne BE. Lower urinary tract infections: bacterial epidemiology and recommendations Prog Urol 2008;18(1 Suppl. FMC):F11-14.

  28. Mozdzan M, Loba J, Ruxer J, Markuszewski L. Fosfomycin in the treatment of recurrent tract infections in type 2 diabetic patients. Pol Arch Med Wewn 2006;115(3):219-226.

  29. Katchman EA, Milo G, Paul M, et al. Three-day vs. longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med 2005;118(11):1196-1207.

  30. Curtis JN. FRCSC Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol 2005;7(1):11-17.

  31. Dwyer PL, O’Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002;14:537-543.

  32. Czaja Ch, Hooton T. Update on acute uncomplicated urinary tract infection in women. Postgrad Med 2006;(1):1119. (On line).

  33. Sen A. Recurrent cystitis in non-pregnant women. Clin Evid 2008;2008. pii: 0801. (Online)

  34. Alexiou Z, Mouktaroudi M, Koratzanis G, et al. The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience. Int J Antimicrob Agents 2007;30(1):40-43.

  35. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001;183(Suppl. 1):S74-S76.

  36. Albert X, Huertas I, Pereiro I, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001209. DOI: 10.1002/14651858.CD001209.pub2.

  37. Kraft JK, Stamey TA. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977;56:55-60.

  38. Brumfitt W, Hamilton-Miller JMT. Efficacy and safety profile of long term nitrofurantoin in urinary tract infection: 18 year’s experience. J Antimicrob Chemother 1998;42:363-371.

  39. Holmberg L, Boman G, Böttiger LE, et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-738.

  40. Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. JAMA 1990;264:703-706.

  41. Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997;157:935-939.

  42. Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 1998;42(3):363-371.

  43. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-268.

  44. U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007;147:128-134.

  45. Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 2005;55(7):420-427.

  46. Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med 1999;170(5):274-277.

  47. UMHS Urinary Tract Infection Guideline, May 2005, University of Michigan. Guidelines for Health System Clinical Care Urinary Tract Infection. Taubman Medical Library .

  48. Cardozo L, Lose G, McClish D, et al. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12(1):15-20.

  49. Shawna L, Johnston SL, Farrell SA, et al. MD, FRCSC, Halifax NS. SCOG Clinical Practice Guidelines. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26(5):503-508.

  50. Rozenberg S, Pastijn A, Gevers R, Murillo D. Estrogen therapy in older patients with recurrent urinary tract infections: a review. Int J Fertil Womens Med 2004;49(2):71-74.

  51. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(4 Suppl. 1):45-51.

  52. Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother 1989;33:92-98.

  53. McMurdo ME, Bissett LY, Price RJ, et al. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005;34(3):256-261.

  54. Kontiokari T, Laitinen J, Jarvi L, et al. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 2003;77(3):600-604.

  55. Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 2005;19(6):861-873.

  56. Guay DR. Cranberry and urinary tract infections. Drugs 2009;69(7):775-807.

  57. Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988;55:173-181.

  58. Howell A B, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 2002;287:3082-3083.

  59. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994;12(4):239-243.

  60. Baeur HW, Rahlfs VW, Lauener PA, Blessmann GSS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents 2002;19:451-456.




2020     |     www.medigraphic.com